SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-18-056046
Filing Date
2018-10-24
Accepted
2018-10-24 16:16:59
Documents
1
Period of Report
2018-10-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 18775
  Complete submission text file 0001209191-18-056046.txt   21229
Mailing Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE X0 CB2 0AA
Business Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE X0 CB2 0AA 011 44 20 7304 5000
ASTRAZENECA PLC (Reporting) CIK: 0000901832 (see all company filings)

Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38697 | Film No.: 181136575
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355 (610) 981-6500
PhaseBio Pharmaceuticals Inc (Issuer) CIK: 0001169245 (see all company filings)

IRS No.: 030375697 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1800 CONCORD PIKE WILMINGTON DE 19803
Business Address 1800 CONCORD PIKE WILMINGTON DE 19803 800-236-9933
Zeneca, Inc. (Reporting) CIK: 0001657583 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 001-38697 | Film No.: 181136576